Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)

SHE:002566 Revenue

Jilin Jian Yisheng Pharmaceutical had revenue of 96.85M CNY in the quarter ending September 30, 2026, a decrease of -34.72%. This brings the company's total for the last twelve months to 599.31M, down -6.23% year-over-year. In the year 2025, Jilin Jian Yisheng Pharmaceutical had annual revenue of 640.17M, down -4.23%. That makes Jilin Jian Yisheng Pharmaceutical the 23,506th largest company in the world by revenue and 4,249th in China.

• Revenue (ttm): 599.31M
• Revenue Growth: -6.23%
• P/S Ratio: 3.39
• Revenue / Employee: 361.90K
• Employees: 1,656
• Market Cap: 2.03B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Industry 514.15M 80.3%
• Health Food Industry 66.77M 10.4%
• Cosmetics Industry 42.52M 6.6%
• Others 16.74M 2.6%

Fiscal year ended Dec 31, 2025 See the full SHE:002566 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	640.17M	-28.30M	-4.23%
Dec 31, 2024	668.47M	-185.20M	-21.69%
Dec 31, 2023	853.66M	23.62M	2.85%
Jan 1, 2023	830.04M	-47.89M	-5.45%
Jan 1, 2022	877.93M	35.34M	4.19%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error